Skip to content
2000
Volume 15, Issue 4
  • ISSN: 1574-8928
  • E-ISSN: 2212-3970

Abstract

Background: RNA splicing, a fundamental step in gene expression, is aimed at intron removal and ordering of exons to form the protein’s reading frame. Objective: This review is focused on the role of RNA splicing in cancer biology; the splicing abnormalities that lead to tumor progression emerge as targets for therapeutic intervention. Methods: We discuss the role of aberrant mRNA splicing in carcinogenesis and drug response. Results and Conclusion: Pharmacological modulation of RNA splicing sets the stage for treatment approaches in situations where mRNA splicing is a clinically meaningful mechanism of the disease.

Loading

Article metrics loading...

/content/journals/pra/10.2174/1574892815666200908122402
2020-11-01
2025-09-01
Loading full text...

Full text loading...

/content/journals/pra/10.2174/1574892815666200908122402
Loading

  • Article Type:
    Review Article
Keyword(s): Cancer; molecular drug targets; protein kinase inhibitors; RNA splicing; therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test